Human Growth hormone market players and analysis by brand, by route of administration, by application, by distribution channel and by region – forecast till 2030. The use of hormones has increased significantly in recent times due to a better understanding of their usage and effects. Market reports connected with the pharmaceutical industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. The market is estimated to accomplish revenues worth USD 9.46 billion while expanding at a CAGR of 9.46% in the course of the forecast period.
One of the main factors driving the growth of the market for human growth hormones is the wide range of illnesses that may be treated by the use of hormones. Growing public awareness about growth hormone therapy is anticipated to increase the market’s potential. The use of hormones in the treatment of cystic fibrosis, burns, wound healing, and for anti-aging effects is anticipated to drive market growth for human growth hormone throughout the anticipated time frame.
The market’s growth curve is being boosted by increased market participants’ dispositions to adapt to new consumers and industry trends, and this trend will continue over the projected period. The market’s growth is also being driven by the expansion of a robust value chain. Due to the launch of new products or the companies in the market increasing their gross revenue, the industry is growing in a promising manner. The market’s vertical supplements and product strategies are enhancing the companies’ potential. Due to favorable product differentiation practices used by market competitors, the tactical aims intended for the market are encouraged. Significant administrative cost reductions are causing the market to grow even more. The effective implementation of strategies is likely to stimulate the market in the coming years.
The notable players shaping the human growth hormone market globally are Zhongshan Hygene Biopharm Co. Ltd., Novo Nordisk A/S, Anhui Anke Biotechnology Co. Ltd., Genetech Inc., Ipsen S.A., Pfizer Inc., Biopartners GmbH, Eli Lilly and Company, Novartis AG, Lifetech Labs, Merck KGaA, and GeneScience Pharmaceuticals Co. Ltd.
The segmentation of the human growth hormone market is carried out on the basis of application, brand, distribution channel, route of administration, and region.
The human growth hormone market has been segmented on the basis of applications into treatment of idiopathic short stature, small for gestational age, growth hormone deficiency, Prader-Will syndrome, Turner syndrome, and others.
The brand-based segmentation of the human growth hormone market comprises of Norditropin, Genotropin, Omnitrope, Humatrope, Saizen, and others.
The segmentation of the market for human growth hormones on the basis of routes of administration consists of intravenous, oral, intramuscular and subcutaneous.
The distribution-based segmentation of the human growth hormones market consists of clinics, retail pharmacies, hospital pharmacies, and e-commerce websites.
Detailed Regional Analysis
The regional analysis of the human growth hormones market observes that the Americas region is responsible for approximately 50% of the human growth hormone market globally owing to the occurrence of growth hormone deficiency and Turner syndrome in the region. The advanced countries in the region such as Canada and the US have reasonably inexpensive hormone therapy, and a firm healthcare system are the main factors motivating the growth of the Americas human growth hormone market.
Furthermore, the healthcare sector in the region has increased government funding which is anticipated to inspire the market development. The European region with its similar growth pattern to the US is responsible for the next major market in the human growth hormone market. Due to the noteworthy market players in the Americas and the European region. The Asia Pacific is expected to observe the swiftest growth at the highest CAGR of 7.60%.
It is projected that a key driver of the regional market will be the increased healthcare spending required to care for the large patient population in the area. The competitors on the global market are stepping up their market activity in the APAC area as they gradually recognise the potential this region holds. The largest country level marketplaces in the APAC area are accounted for by countries like Japan, China, and India. The good perception of HGH and its use in the treatment of short stature is anticipated to boost demand for growth hormone therapy.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)